These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39043719)

  • 1. Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia.
    Khurana MP; Curran-Sebastian J; Bhatt S; Knight GM
    Sci Rep; 2024 Jul; 14(1):16986. PubMed ID: 39043719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): a quasi-experimental, ecological, data linkage study.
    Aliabadi S; Anyanwu P; Beech E; Jauneikaite E; Wilson P; Hope R; Majeed A; Muller-Pebody B; Costelloe C
    Lancet Infect Dis; 2021 Dec; 21(12):1689-1700. PubMed ID: 34363774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential interventions for an antimicrobial stewardship bundle for Escherichia coli bacteraemia.
    Birrell MT; Horne K; Rogers BA
    Int J Antimicrob Agents; 2021 Apr; 57(4):106301. PubMed ID: 33588016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia.
    Giménez-Pérez M; Hernández S; Padullés A; Boix-Palop L; Grau S; Badia JM; Ferrer R; Calbo E; Limón E; Pujol M; Horcajada JP;
    Int J Antimicrob Agents; 2024 Aug; 64(2):107202. PubMed ID: 38768736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.
    Haruki Y; Hagiya H; Haruki M; Sugiyama T
    J Infect Chemother; 2018 Nov; 24(11):944-947. PubMed ID: 29803763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
    Kunz Coyne AJ; Casapao AM; Isache C; Morales J; McCarter YS; Jankowski CA
    Microbiol Spectr; 2021 Oct; 9(2):e0046421. PubMed ID: 34704795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Blot S; Vandijck D; Vandewoude K; Depuydt P; Vogelaers D; Peleman R
    J Antimicrob Chemother; 2007 Dec; 60(6):1402. PubMed ID: 17913718
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic Exposure in the Community and Resistance Patterns of Escherichia coli Community-Acquired Bloodstream Infection.
    Gottesman BS; Shitrit P; Katzir M; Chowers M
    Isr Med Assoc J; 2018 Jun; 20(6):382-384. PubMed ID: 29911761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
    Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
    BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
    Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-resistant Escherichia coli bacteraemia: relation to empiric therapy and clinical outcome.
    Andersen NF; Møller J; Peterslund NA
    Scand J Infect Dis; 2005; 37(2):90-5. PubMed ID: 15764199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
    Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
    Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing
    Benanti GE; Brown ART; Shigle TL; Tarrand JJ; Bhatti MM; McDaneld PM; Shelburne SA; Aitken SL
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
    Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ;
    Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.
    Heng ST; Chen SL; Wong JGX; Lye DC; Ng TM
    Sci Rep; 2018 Aug; 8(1):12785. PubMed ID: 30143706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study.
    Hernandez-Santiago V; Davey PG; Nathwani D; Marwick CA; Guthrie B
    PLoS Med; 2019 Jun; 16(6):e1002825. PubMed ID: 31173597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.